Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365.

Journal of medicinal chemistry·2026
Same author

Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud Irishman.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Single-cell epigenetic landscape, microenvironment interactions, and gene regulatory modules of non-functioning pituitary adenomas.

Cell systems·2026
Same author

Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud Irishman.

Proceedings of the National Academy of Sciences of the United States of America·2026

Video Experimental Relacionado

Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Terapia hormonal: la complejidad fisiológica desmiente la simplicidad terapéutica.

Judith L Turgeon1, Donald P McDonnell, Kathryn A Martin

  • 1Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California-Davis, Davis, CA 95616, USA. jlturgeon@ucdavis.edu

Science (New York, N.Y.)
|May 29, 2004
PubMed
Resumen

Los resultados de la terapia hormonal posmenopáusica (HT) son objeto de debate. Comprender las acciones de estrógeno y progestina a nivel molecular es clave para refinar los protocolos de HT y el desarrollo de fármacos.

Más Videos Relacionados

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Videos de Experimentos Relacionados

Last Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Área de la Ciencia:

  • Endocrinología y Biología Molecular.
  • Salud reproductiva y salud reproductiva.

Sus antecedentes:

  • El estudio de la Iniciativa de Salud de la Mujer tenía como objetivo aclarar los riesgos y beneficios de la terapia hormonal posmenopáusica (HT).
  • Los resultados del estudio generaron un importante debate y confusión entre los profesionales de la salud y el público.
  • La menopausia implica una disminución en las hormonas ováricas (estrógeno y progesterona), que afectan a varios tejidos corporales.

Objetivo del estudio:

  • Para revisar las acciones específicas de los tejidos de estrógeno y progestina.
  • Evaluar la integración de los conocimientos de endocrinología de la hormona esteroide en los estudios clínicos.
  • Considerar el impacto en los protocolos actuales de terapia hormonal y los avances farmacéuticos.

Principales métodos:

  • Revisión de la literatura científica actual sobre las acciones de los estrógenos y las progestinas.
  • Análisis de cómo los conocimientos de la endocrinología molecular informan el diseño del ensayo clínico.
  • Evaluación de la influencia en las estrategias contemporáneas de terapia hormonal.

Principales resultados:

  • Los avances en biología molecular están definiendo las acciones diferenciales de las hormonas esteroides.
  • Comprender estos mecanismos moleculares es crucial para interpretar los hallazgos clínicos.
  • El conocimiento existente de la endocrinología se ha incorporado de manera variable en los estudios clínicos.

Conclusiones:

  • Una comprensión molecular más profunda del estrógeno y la progestina es esencial para resolver las controversias de HT.
  • Una mejor integración de la investigación endocrinológica puede optimizar los protocolos de terapia hormonal.
  • Este conocimiento es vital para el futuro desarrollo farmacéutico en la salud de la mujer.